Cargando…

New HIV peptide-based immunoassay resolves vaccine-induced seropositivity in HIV vaccine (Phase III) trial participants

Detalles Bibliográficos
Autores principales:	Penezina, O, Clapham, D, Collins, J, Kovalenko, V, Krueger, N, Rodriguez-Chavez, IR, Busch, MP, Levin, AE
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441408/ http://dx.doi.org/10.1186/1742-4690-9-S2-P120

Ejemplares similares

P14-11. Educating community medical providers about HIV vaccine induced seropositivity
por: Mark, KE, et al.
Publicado: (2009)

Plasma folate in HIV-seropositive patients
por: Wiwanitkit, Viroj
Publicado: (2011)

P15-05. Evaluation and recommendations on good clinical laboratory practice (GCLP) guidelines for phase I-III HIV vaccine clinical trials
por: Sarzotti-Kelsoe, M, et al.
Publicado: (2009)

P14-04. HIV-SELECTEST EIA and rapid test: a novel assay for differential diagnosis of HIV infections in the face of vaccine-generated antibodies
por: Khurana, S, et al.
Publicado: (2009)

Study of pulmonary involvement in HIV-seropositive patients
por: Nair, Girija, et al.
Publicado: (2012)

Disclosure to HIV-seropositive children in rural Zambia
por: Tsuzuki, Shinya, et al.
Publicado: (2018)

Serologic screening of United States blood donors for Babesia microti using an investigational enzyme immunoassay
por: Levin, Andrew E., et al.
Publicado: (2016)

Willingness to Participate in HIV Therapeutic Vaccine Trials among HIV-Infected Patients on ART in China
por: Dong, Yuan, et al.
Publicado: (2014)

Phenotypic Alteration of Neutrophils in the Blood of HIV Seropositive Patients
por: Cloke, Tom, et al.
Publicado: (2013)

Opportunistic Infections in HIV Seropositive Individuals: CME Lecture
por: Gazzard, B G
Publicado: (1995)

Prevalence of Malassezia species on the skin of HIV-seropositive patients
por: Krzyściak, Paweł, et al.
Publicado: (2020)

Vaccine: friend or foe? Double seropositive vasculitis following influenza vaccination
por: Norton, Benjamin, et al.
Publicado: (2019)

The Influence of Community Members on Participation by Youth in an HIV Vaccine Trial in Tanzania
por: Mbunda, Theodora, et al.
Publicado: (2016)

Volunteer motivators for participating in HIV vaccine clinical trials in Nairobi, Kenya
por: Nyaoke, Borna A., et al.
Publicado: (2017)

Under consent: participation of people with HIV in an Ebola vaccine trial in Canada
por: David, Pierre-Marie, et al.
Publicado: (2021)

Perceived HIV-Associated Stigma among HIV-Seropositive Men: Psychometric Study of HIV Stigma Scale
por: Valle, Adrian, et al.
Publicado: (2015)

Risk Factors Associated with HIV Acquisition in Males Participating in HIV Vaccine Efficacy Trials in South Africa
por: Malahleha, Mookho, et al.
Publicado: (2023)

Lanthanide-based time-resolved luminescence immunoassays
por: Hagan, A. K., et al.
Publicado: (2011)

Biotin Interference in Point of Care HIV Immunoassay
por: Haleyur Giri Setty, Mohan Kumar, et al.
Publicado: (2020)

Progression of cervical neoplasia in HIV-seropositive women with and without antiretroviral therapy in Johannesburg, South Africa
por: Firnhaber, Cynthia, et al.
Publicado: (2010)

Outcomes of hysterectomy in HIV-seropositive women compared to seronegative women.
por: Franz, Jennifer, et al.
Publicado: (2005)

Extranodal non-Hodgkin’s lymphoma of the gingiva in an HIV seropositive patient
por: Patil, Karthikeya, et al.
Publicado: (2010)

Erythrocyte Inosine Triphosphatase Activity Is Decreased in HIV-Seropositive Individuals
por: Bierau, Jörgen, et al.
Publicado: (2012)

Lower genital tract infections in HIV-seropositive women in India
por: Goel, Vandana, et al.
Publicado: (2011)

Clinico-microbiological study of opportunistic infection in HIV seropositive patients
por: Patel, Sangeeta D., et al.
Publicado: (2011)

SOCIODEMOGRAPHIC PROFILE AND PSYCHIATRIC MORBIDITY IN HIV-SEROPOSITIVE DEFENCE PERSONNEL
por: Madan, P.C., et al.
Publicado: (1997)

Pregnancy and birth in HIV seropositive women - present stage results
por: Mitran, Mihai, et al.
Publicado: (2013)

Lymph nodes cytology in HIV seropositive cases with haematological alterations
por: Tirumalasetti, Neelima, et al.
Publicado: (2014)

Oral Kaposi's sarcoma: Sole presentation in HIV seropositive patient
por: Arul, A. Sri Kennath J., et al.
Publicado: (2015)

Experiences of adolescents seropositive for HIV/AIDS: a qualitative study
por: Galano, Eliana, et al.
Publicado: (2016)

Dermatological Opportunistic Infections in HIV Seropositive Patients: An Observational Study
por: Basida, Sanket D, et al.
Publicado: (2021)

Serum electrolytes and renal alterations in HIV-seropositive Mexican subjects
por: Garza Tovar, Oscar Antonio, et al.
Publicado: (2021)

Seroprevalence of Toxoplasma gondii in newly diagnosed HIV seropositive patients
por: Dutta, Anuja, et al.
Publicado: (2020)

Correction to: Under consent: participation of people with HIV in an Ebola vaccine trial in Canada
por: David, Pierre-Marie, et al.
Publicado: (2021)

The Relationship between Cocaine Use and Human Papillomavirus Infections in HIV-Seropositive and HIV-Seronegative Women
por: Minkoff, Howard, et al.
Publicado: (2008)

Prevalence of Abnormalities in Vestibular Function and Balance among HIV-Seropositive and HIV-Seronegative Women and Men
por: Cohen, Helen S., et al.
Publicado: (2012)

Enteric viruses in HIV-1 seropositive and HIV-1 seronegative children with diarrheal diseases in Brazil
por: Portes, Silvana Augusta Rodrigues, et al.
Publicado: (2017)

HIV prevention by vaccine
por: Gallo, Robert
Publicado: (2012)

The HIV vaccine saga
por: Smith, Kendall A
Publicado: (2003)

Prospecting for an HIV vaccine
por: Brett-Major, D. M., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_4g7pgaelrl99vju5g2kplr42p1